PTX3 and neoplasm: Concurrently, our GSEA results implied that PTX3 engaged in tumor immune and metabolism pathways such as the “inflammatory response”, “complement”, “KRAS signaling”, “arginine and proline metabolism”, and “Toll-like receptor signaling pathway”.